Acute Myeloid Leukemia in Remission

general

A finding of acute myeloid leukemia that is not growing and responds to treatment.

Centers

Active Trials

$13.3B

Cancer Funding

Specific Cancer Types(2)

Name	Centers	Active Trials
Adult Acute Myeloid Leukemia in Remission	65	—
Childhood Acute Myeloid Leukemia in Remission	52	—

Top Centers for Acute Myeloid Leukemia in Remission(66)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive High-Volume Research Center	High-Volume Research Center	2	—	78.8
2	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	67.7
3	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program	Active Research Program	1	—	66.0
4	Boston University Cancer CenterBoston, MA Active Research Program	Active Research Program	2	—	64.6
5	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX Active Research Program	Active Research Program	1	—	61.0
6	University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program	Active Research Program	—	—	54.0
7	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program	Active Research Program	—	—	52.3
8	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program	Active Research Program	—	—	45.6
9	Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program	Active Research Program	—	—	44.0
10	Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program	Active Research Program	—	—	40.6
11	Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program	Active Research Program	—	—	39.0
12	Cleveland Clinic Cancer CenterCleveland, OH		—	—	36.5
13	UCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco, CA NCI Comprehensive		—	$831M	—
14	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD NCI Comprehensive		—	$738M	—
15	Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive		—	$737M	—
16	Siteman Cancer CenterSt. Louis, MO NCI Comprehensive		—	$604M	—
17	UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive		—	$569M	—
18	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive		—	$534M	—
19	Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive		—	$517M	—
20	Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive		—	$509M	—
21	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive		—	$507M	—
22	Dan L Duncan Comprehensive Cancer Center at Baylor College of MedicineHouston, TX NCI Comprehensive		—	$484M	—
23	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive		—	$472M	—
24	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive		—	$452M	—
25	Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX NCI Comprehensive		—	$438M	—
26	Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY NCI Comprehensive		—	$392M	—
27	Winship Cancer InstituteAtlanta, GA NCI Comprehensive		—	$375M	—
28	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive		—	$370M	—
29	Masonic Cancer CenterMinneapolis, MN NCI Comprehensive		—	$368M	—
30	OHSU Knight Cancer InstitutePortland, OR NCI Comprehensive		—	$354M	—
31	USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive		—	$333M	—
32	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive		—	$276M	—
33	Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive		—	$262M	—
34	UF Health Cancer InstituteGainesville, FL NCI Clinical		—	$257M	—
35	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive		—	$223M	—
36	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive		—	$222M	—
37	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical		—	$194M	—
38	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive		—	$186M	—
39	Cedars-Sinai CancerLos Angeles, CA		—	$179M	—
40	Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive		—	$146M	—
41	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical		—	$143M	—
42	Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA NCI Comprehensive		—	$136M	—
43	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive		—	$134M	—
44	Dartmouth Cancer CenterLebanon, NH NCI Comprehensive		—	$130M	—
45	University of Illinois Cancer CenterChicago, IL		—	$122M	—
46	University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical		—	$116M	—
47	University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive		—	$110M	—
48	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR		—	$106M	—
49	Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive		—	$103M	—
50	Karmanos Cancer InstituteDetroit, MI NCI Comprehensive		—	$94M	—
51	Cancer Center at IllinoisUrbana, IL		—	$81M	—
52	Stony Brook Cancer CenterStony Brook, NY		—	$79M	—
53	Penn State Cancer InstituteHershey, PA		—	$73M	—
54	University of Cincinnati Cancer CenterCincinnati, OH		—	$71M	—
55	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL		—	$59M	—
56	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ		—	$58M	—
57	Georgia Cancer Center, Augusta UniversityAugusta, GA		—	$53M	—
58	The University of Vermont Cancer CenterBurlington, VT		—	$43M	—
59	University of Puerto Rico Comprehensive Cancer CenterSan Juan, PR		—	$34M	—
60	Northwell Health Cancer InstituteNew York, NY		—	$18M	—
61	Upstate Cancer CenterSyracuse, NY		—	$15M	—
62	Loma Linda University Cancer CenterLoma Linda, CA		—	$10M	—
63	Princess Margaret Cancer CentreToronto, ON		—	—	—
64	Tampa General Hospital Cancer InstituteTampa, FL		—	—	—
65	Louisiana Cancer Research CenterNew Orleans, LA		—	—	—
66	BC CancerVancouver, BC		—	—	—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →